skip to content
Covid-19 virus
COVID-19 Resources

Reliable information about the coronavirus (COVID-19) is available from the World Health Organization (current situation, international travel). Numerous and frequently-updated resource results are available from this WorldCat.org search. OCLC’s WebJunction has pulled together information and resources to assist library staff as they consider how to handle coronavirus issues in their communities.

Image provided by: CDC/ Alissa Eckert, MS; Dan Higgins, MAM
Évaluation économique des inhibiteurs des récepteurs à la glycoprotéine llb-llla en prévision d'une intervention coronaire percutanée accompagnée de la pose de stents Preview this item
ClosePreview this item
Checking...

Évaluation économique des inhibiteurs des récepteurs à la glycoprotéine llb-llla en prévision d'une intervention coronaire percutanée accompagnée de la pose de stents

Author: Allan Brown; Canadian Coordinating Office for Health Technology Assessment.
Publisher: Ottawa, Ont. : Office canadien de coordination de l'évaluation des technologies de la santé, (Ottawa, Ontario : Canadian Electronic Library, 2005. 2009)
Series: Technology report (Canadian Coordinating Office for Health Technology Assessment), issue 54.
Edition/Format:   eBook : Document : FrenchView all editions and formats
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Electronic books
Livres électroniques
Additional Physical Format: Version imprimée:
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Allan Brown; Canadian Coordinating Office for Health Technology Assessment.
OCLC Number: 1078468863
Description: 1 ressource en ligne (1 texte électronique (x, 86 pages)) : illustrations, numérique, fichier PDF
Series Title: Technology report (Canadian Coordinating Office for Health Technology Assessment), issue 54.
Other Titles: Economic evaluation of glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention with stenting
Responsibility: Allan Brown [et autres].
More information:

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


\n\n

Primary Entity<\/h3>\n
<http:\/\/www.worldcat.org\/oclc\/1078468863<\/a>> # \u00C9valuation \u00E9conomique des inhibiteurs des r\u00E9cepteurs \u00E0 la glycoprot\u00E9ine llb-llla en pr\u00E9vision d\'une intervention coronaire percutan\u00E9e accompagn\u00E9e de la pose de stents<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:MediaObject<\/a>, schema:Book<\/a>, schema:CreativeWork<\/a> ;\u00A0\u00A0\u00A0\nlibrary:oclcnum<\/a> \"1078468863<\/span>\" ;\u00A0\u00A0\u00A0\nlibrary:placeOfPublication<\/a> <http:\/\/id.loc.gov\/vocabulary\/countries\/quc<\/a>> ;\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/glycoproteines<\/a>> ; # Glycoprot\u00E9ines<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/biomedical_technology<\/a>> ; # Biomedical Technology<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/evaluation_studies<\/a>> ; # Evaluation Studies<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/platelet_glycoprotein_gpiib_iiia_complex_inhibitors<\/a>> ; # Platelet glycoprotein GPIIb-IIIa complex--Inhibitors<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/coronary_heart_disease_treatment<\/a>> ; # Coronary heart disease--Treatment<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/analyse_cout_benefice<\/a>> ; # Analyse co\u00FBt b\u00E9n\u00E9fice<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/angor_instable_chimiotherapie<\/a>> ; # Angor instable--Chimioth\u00E9rapie<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/dewey.info\/class\/616.1061\/e21\/<\/a>> ;\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/coronary_disease_therapy<\/a>> ; # Coronary Disease--therapy<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/angioplastie_transluminale_evaluation<\/a>> ; # Angioplastie transluminale--\u00C9valuation<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/etudes_d_evaluation<\/a>> ; # \u00C9tudes d\'\u00E9valuation<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/glycoproteins<\/a>> ; # Glycoproteins<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/maladie_coronaire_therapie<\/a>> ; # Maladie coronaire--Th\u00E9rapie<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/endoprotheses_utilisation<\/a>> ; # Endoproth\u00E8ses--Utilisation<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/cost_benefit_analysis<\/a>> ; # Cost-Benefit Analysis<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/technologie_biomedicale_economie<\/a>> ; # Technologie biom\u00E9dicale--\u00C9conomie<\/span>\n\u00A0\u00A0\u00A0\nschema:alternateName<\/a> \"Economic evaluation of glycoprotein IIb\/IIIa inhibitors in patients undergoing percutaneous coronary intervention with stenting<\/span>\" ;\u00A0\u00A0\u00A0\nschema:bookFormat<\/a> schema:EBook<\/a> ;\u00A0\u00A0\u00A0\nschema:contributor<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Person\/brown_allan<\/a>> ; # Allan Brown<\/span>\n\u00A0\u00A0\u00A0\nschema:contributor<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Organization\/canadian_coordinating_office_for_health_technology_assessment<\/a>> ; # Canadian Coordinating Office for Health Technology Assessment.<\/span>\n\u00A0\u00A0\u00A0\nschema:datePublished<\/a> \"2005<\/span>\" ;\u00A0\u00A0\u00A0\nschema:exampleOfWork<\/a> <http:\/\/worldcat.org\/entity\/work\/id\/449306128<\/a>> ;\u00A0\u00A0\u00A0\nschema:genre<\/a> \"Livres \u00E9lectroniques<\/span>\"@fr<\/a> ;\u00A0\u00A0\u00A0\nschema:genre<\/a> \"Electronic books<\/span>\"@fr<\/a> ;\u00A0\u00A0\u00A0\nschema:inLanguage<\/a> \"fr<\/span>\" ;\u00A0\u00A0\u00A0\nschema:isPartOf<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Series\/technology_report_canadian_coordinating_office_for_health_technology_assessment<\/a>> ; # Technology report (Canadian Coordinating Office for Health Technology Assessment) ;<\/span>\n\u00A0\u00A0\u00A0\nschema:isPartOf<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Series\/rapport_technologique_office_canadien_de_coordination_de_l_evaluation_des_technologies_de_la_sante<\/a>> ; # Rapport technologique \/ Office canadien de coordination de l\'\u00E9valuation des technologies de la sant\u00E9 ;<\/span>\n\u00A0\u00A0\u00A0\nschema:isSimilarTo<\/a> <http:\/\/worldcat.org\/entity\/work\/data\/449306128#CreativeWork\/<\/a>> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"\u00C9valuation \u00E9conomique des inhibiteurs des r\u00E9cepteurs \u00E0 la glycoprot\u00E9ine llb-llla en pr\u00E9vision d\'une intervention coronaire percutan\u00E9e accompagn\u00E9e de la pose de stents<\/span>\"@fr<\/a> ;\u00A0\u00A0\u00A0\nschema:productID<\/a> \"1078468863<\/span>\" ;\u00A0\u00A0\u00A0\nschema:url<\/a> <https:\/\/www.deslibris.ca\/ID\/215136<\/a>> ;\u00A0\u00A0\u00A0\nschema:url<\/a> <http:\/\/site.ebrary.com\/id\/10264491<\/a>> ;\u00A0\u00A0\u00A0\nschema:url<\/a> <http:\/\/files.deslibris.ca\/cppc\/215\/215136.pdf<\/a>> ;\u00A0\u00A0\u00A0\nwdrs:describedby<\/a> <http:\/\/www.worldcat.org\/title\/-\/oclc\/1078468863<\/a>> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n\n

Related Entities<\/h3>\n
<http:\/\/dewey.info\/class\/616.1061\/e21\/<\/a>>\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Organization\/canadian_coordinating_office_for_health_technology_assessment<\/a>> # Canadian Coordinating Office for Health Technology Assessment.<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Organization<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Canadian Coordinating Office for Health Technology Assessment.<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Person\/brown_allan<\/a>> # Allan Brown<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Person<\/a> ;\u00A0\u00A0\u00A0\nschema:familyName<\/a> \"Brown<\/span>\" ;\u00A0\u00A0\u00A0\nschema:givenName<\/a> \"Allan<\/span>\" ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Allan Brown<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Series\/rapport_technologique_office_canadien_de_coordination_de_l_evaluation_des_technologies_de_la_sante<\/a>> # Rapport technologique \/ Office canadien de coordination de l\'\u00E9valuation des technologies de la sant\u00E9 ;<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nbgn:PublicationSeries<\/a> ;\u00A0\u00A0\u00A0\nschema:hasPart<\/a> <http:\/\/www.worldcat.org\/oclc\/1078468863<\/a>> ; # \u00C9valuation \u00E9conomique des inhibiteurs des r\u00E9cepteurs \u00E0 la glycoprot\u00E9ine llb-llla en pr\u00E9vision d\'une intervention coronaire percutan\u00E9e accompagn\u00E9e de la pose de stents<\/span>\n\u00A0\u00A0\u00A0\nschema:name<\/a> \"Rapport technologique \/ Office canadien de coordination de l\'\u00E9valuation des technologies de la sant\u00E9 ;<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Series\/technology_report_canadian_coordinating_office_for_health_technology_assessment<\/a>> # Technology report (Canadian Coordinating Office for Health Technology Assessment) ;<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nbgn:PublicationSeries<\/a> ;\u00A0\u00A0\u00A0\nschema:hasPart<\/a> <http:\/\/www.worldcat.org\/oclc\/1078468863<\/a>> ; # \u00C9valuation \u00E9conomique des inhibiteurs des r\u00E9cepteurs \u00E0 la glycoprot\u00E9ine llb-llla en pr\u00E9vision d\'une intervention coronaire percutan\u00E9e accompagn\u00E9e de la pose de stents<\/span>\n\u00A0\u00A0\u00A0\nschema:name<\/a> \"Technology report (Canadian Coordinating Office for Health Technology Assessment) ;<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/analyse_cout_benefice<\/a>> # Analyse co\u00FBt b\u00E9n\u00E9fice<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Analyse co\u00FBt b\u00E9n\u00E9fice<\/span>\"@fr<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/angioplastie_transluminale_evaluation<\/a>> # Angioplastie transluminale--\u00C9valuation<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Angioplastie transluminale--\u00C9valuation<\/span>\"@fr<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/angor_instable_chimiotherapie<\/a>> # Angor instable--Chimioth\u00E9rapie<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Angor instable--Chimioth\u00E9rapie<\/span>\"@fr<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/biomedical_technology<\/a>> # Biomedical Technology<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Biomedical Technology<\/span>\"@fr<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/coronary_disease_therapy<\/a>> # Coronary Disease--therapy<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Coronary Disease--therapy<\/span>\"@fr<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/coronary_heart_disease_treatment<\/a>> # Coronary heart disease--Treatment<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Coronary heart disease--Treatment<\/span>\"@fr<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/cost_benefit_analysis<\/a>> # Cost-Benefit Analysis<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Cost-Benefit Analysis<\/span>\"@fr<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/endoprotheses_utilisation<\/a>> # Endoproth\u00E8ses--Utilisation<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Endoproth\u00E8ses--Utilisation<\/span>\"@fr<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/etudes_d_evaluation<\/a>> # \u00C9tudes d\'\u00E9valuation<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"\u00C9tudes d\'\u00E9valuation<\/span>\"@fr<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/evaluation_studies<\/a>> # Evaluation Studies<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Evaluation Studies<\/span>\"@fr<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/glycoproteines<\/a>> # Glycoprot\u00E9ines<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Glycoprot\u00E9ines<\/span>\"@fr<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/glycoproteins<\/a>> # Glycoproteins<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Glycoproteins<\/span>\"@fr<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/maladie_coronaire_therapie<\/a>> # Maladie coronaire--Th\u00E9rapie<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Maladie coronaire--Th\u00E9rapie<\/span>\"@fr<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/platelet_glycoprotein_gpiib_iiia_complex_inhibitors<\/a>> # Platelet glycoprotein GPIIb-IIIa complex--Inhibitors<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Platelet glycoprotein GPIIb-IIIa complex--Inhibitors<\/span>\"@fr<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/449306128#Topic\/technologie_biomedicale_economie<\/a>> # Technologie biom\u00E9dicale--\u00C9conomie<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Technologie biom\u00E9dicale--\u00C9conomie<\/span>\"@fr<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/id.loc.gov\/vocabulary\/countries\/quc<\/a>>\u00A0\u00A0\u00A0\u00A0a \nschema:Place<\/a> ;\u00A0\u00A0\u00A0\ndcterms:identifier<\/a> \"quc<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/worldcat.org\/entity\/work\/data\/449306128#CreativeWork\/<\/a>>\u00A0\u00A0\u00A0\u00A0a \nschema:CreativeWork<\/a> ;\u00A0\u00A0\u00A0\nschema:description<\/a> \"Version imprim\u00E9e:<\/span>\" ;\u00A0\u00A0\u00A0\nschema:isSimilarTo<\/a> <http:\/\/www.worldcat.org\/oclc\/1078468863<\/a>> ; # \u00C9valuation \u00E9conomique des inhibiteurs des r\u00E9cepteurs \u00E0 la glycoprot\u00E9ine llb-llla en pr\u00E9vision d\'une intervention coronaire percutan\u00E9e accompagn\u00E9e de la pose de stents<\/span>\n\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/www.worldcat.org\/title\/-\/oclc\/1078468863<\/a>>\u00A0\u00A0\u00A0\u00A0a \ngenont:InformationResource<\/a>, genont:ContentTypeGenericResource<\/a> ;\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/www.worldcat.org\/oclc\/1078468863<\/a>> ; # \u00C9valuation \u00E9conomique des inhibiteurs des r\u00E9cepteurs \u00E0 la glycoprot\u00E9ine llb-llla en pr\u00E9vision d\'une intervention coronaire percutan\u00E9e accompagn\u00E9e de la pose de stents<\/span>\n\u00A0\u00A0\u00A0\nschema:dateModified<\/a> \"2020-04-28<\/span>\" ;\u00A0\u00A0\u00A0\nvoid:inDataset<\/a> <http:\/\/purl.oclc.org\/dataset\/WorldCat<\/a>> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n\n

Content-negotiable representations<\/p>\n